Lv1
30 积分 2025-08-12 加入
Epidemiological characteristics and disease burden of childhood neuroblastoma in Asia: trends and regional differences over the past 30 years
3个月前
已关闭
High-risk neuroblastoma as a model for immunotherapy of non-immunogenic cancers: where might we be in 20 years?
5个月前
已完结
Naxitamab-combination Therapy for the Treatment of Patients With Refractory and/or Relapsed High-risk Neuroblastoma
7个月前
已完结
Author Correction: Clonal evolution during metastatic spread in high-risk neuroblastoma
7个月前
已完结
Paediatric Strategy Forum for Medicinal Product Development of Cyclin-Dependent Kinase Inhibitors in Children and Adolescents ACCELERATE in collaboration with the European Medicines Agency With participation of the Food and Drug Administration
7个月前
已完结
A phase II trial of Naxitamab plus stepped-up dosing of GM-CSF for patients with high-risk neuroblastoma in first complete remission
7个月前
已完结
皖公网安备34019202002308
